Fortitude Group, Inc. (FRTD)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Fortitude Group, Inc. (FRTD) ein Financial Services-Unternehmen mit einer Bewertung von 0. Bewertet mit 48/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Fortitude Group, Inc. (FRTD) Finanzdienstleistungsprofil
Fortitude Group Inc. operates within the financial services sector, focusing on asset management and developing solutions for the medical community. The company's portfolio includes medical devices and advanced technology, aiming to improve patient outcomes and prevent risks. It faces competition from established asset management firms and medical technology companies.
Investmentthese
Investing in Fortitude Group Inc. presents a speculative opportunity given its focus on the medical device and technology sector. Key value drivers include the successful development and commercialization of its product portfolio, which aims to improve patient outcomes and prevent risks. Growth catalysts involve expanding its market reach through strategic partnerships and acquisitions. However, potential investors may want to evaluate the risks associated with the company's OTC market listing, limited financial disclosure, and high beta of 8.68, indicating significant volatility. The company's ability to secure funding for research and development and navigate regulatory hurdles will be critical for its long-term success.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Fortitude Group Inc. focuses on developing solutions for the medical community, including medical devices and advanced technology.
- The company aims to improve patient outcomes by preventing risks through its products and procedures.
- Fortitude Group operates through direct holdings, subsidiaries, and joint ventures.
- The company was formerly known as Rounder, Inc., changing its name to Fortitude Group, Inc. in January 2013.
- The company's beta is 8.68, indicating high volatility compared to the market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Focus on medical device and technology solutions
- Potential for improving patient outcomes
- Operates through diverse holdings and ventures
- Commitment to preventing risks in healthcare
Schwaechen
- OTC market listing indicates higher risk
- Limited financial disclosure
- High beta suggests significant volatility
- Dependence on successful product development
Katalysatoren
- Ongoing: Development and commercialization of new medical devices.
- Ongoing: Expansion of strategic partnerships with healthcare providers.
- Upcoming: Potential acquisitions of complementary businesses.
- Ongoing: Geographic expansion into international markets.
- Ongoing: Leveraging advanced technologies to enhance product offerings.
Risiken
- Potential: Regulatory hurdles and compliance costs.
- Ongoing: Competition from established medical device companies.
- Potential: Technological obsolescence.
- Potential: Economic downturn affecting healthcare spending.
- Ongoing: Risks associated with OTC market listing and limited financial disclosure.
Wachstumschancen
- Expansion of Product Portfolio: Fortitude Group can drive growth by expanding its portfolio of medical devices and advanced technology solutions. The global medical device market is projected to reach $600 billion by 2028, offering a substantial opportunity for growth. By investing in research and development, Fortitude Group can introduce innovative products that address unmet needs in the healthcare sector, enhancing its competitive position and market share. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Fortitude Group can accelerate its growth by forming strategic partnerships and acquiring complementary businesses. Collaborating with established healthcare providers and technology companies can provide access to new markets and distribution channels. The company can also acquire smaller, innovative companies to expand its product portfolio and technological capabilities. Timeline: Ongoing.
- Geographic Expansion: Fortitude Group can expand its geographic reach beyond the United States to tap into international markets. The global healthcare market is experiencing rapid growth, particularly in emerging economies. By establishing a presence in key international markets, Fortitude Group can diversify its revenue streams and reduce its reliance on the domestic market. Timeline: 2027-2029.
- Focus on Patient-Centric Solutions: Fortitude Group can differentiate itself by focusing on developing patient-centric solutions that improve outcomes and enhance the patient experience. The healthcare industry is increasingly emphasizing patient engagement and personalized care. By incorporating patient feedback into its product development process, Fortitude Group can create solutions that better meet the needs of patients and healthcare providers. Timeline: Ongoing.
- Leveraging Advanced Technology: Fortitude Group can leverage advanced technologies such as artificial intelligence, machine learning, and data analytics to enhance its product offerings and improve operational efficiency. These technologies can be used to develop more sophisticated medical devices, optimize treatment protocols, and personalize patient care. By embracing technological innovation, Fortitude Group can gain a competitive advantage and drive long-term growth. Timeline: Ongoing.
Chancen
- Expansion of product portfolio
- Strategic partnerships and acquisitions
- Geographic expansion into international markets
- Leveraging advanced technologies
Risiken
- Regulatory hurdles and compliance costs
- Competition from established medical device companies
- Technological obsolescence
- Economic downturn affecting healthcare spending
Wettbewerbsvorteile
- Proprietary medical device technology
- Strategic partnerships with healthcare providers
- Focus on patient-centric solutions
Ueber FRTD
Fortitude Group Inc., headquartered in Erie, Pennsylvania, is dedicated to developing solutions for the medical community. The company, through its direct holdings, subsidiaries, and joint ventures, focuses on utilizing a product portfolio that includes medical devices, advanced technology, and medical protocol procedures. These are engineered to prevent risk and improve patient outcomes. Founded with the goal of addressing critical needs within the healthcare sector, Fortitude Group has evolved from its origins as Rounder, Inc., officially changing its name in January 2013 to reflect its new strategic direction. The company's current market position involves leveraging its diverse portfolio to offer integrated solutions that enhance patient care and safety. By combining medical devices with advanced technological applications, Fortitude Group aims to provide comprehensive solutions that address the evolving challenges in healthcare. Its geographic reach is primarily within the United States, with potential for expansion as its product portfolio grows. Fortitude Group competes with other companies in the medical device and healthcare technology sectors, striving to differentiate itself through innovation and a focus on patient-centric solutions.
Was das Unternehmen tut
- Develops solutions for the medical community.
- Focuses on medical devices and advanced technology.
- Aims to improve patient outcomes.
- Engineers products to prevent risk.
- Operates through direct holdings, subsidiaries, and joint ventures.
- Offers medical protocol procedures.
Geschaeftsmodell
- Develops and markets medical devices.
- Creates advanced technology solutions for healthcare.
- Generates revenue through product sales and licensing agreements.
Branchenkontext
Fortitude Group Inc. operates within the asset management industry, focusing on the medical device and healthcare technology sectors. The industry is characterized by rapid innovation, increasing regulatory scrutiny, and a growing demand for patient-centric solutions. The competitive landscape includes established medical device manufacturers, technology companies, and specialized healthcare providers. Fortitude Group aims to differentiate itself through its integrated approach, combining medical devices with advanced technology to improve patient outcomes. The company's success will depend on its ability to navigate the evolving market dynamics and capitalize on emerging opportunities in the healthcare sector.
Wichtige Kunden
- Hospitals and medical centers
- Healthcare providers
- Patients
Finanzdaten
Chart & Info
Fortitude Group, Inc. (FRTD) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer FRTD verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer FRTD.
Kursziele
Wall-Street-Kurszielanalyse fuer FRTD.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von FRTD auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Thomas J. Parilla
CEO
Thomas J. Parilla serves as the Chief Executive Officer of Fortitude Group Inc. His background includes experience in corporate management and strategic development. Parilla has been involved in guiding the company's transition and growth initiatives, focusing on expanding its presence in the medical solutions market. His leadership is centered on driving innovation and improving patient outcomes through the company's product portfolio. Additional details regarding his specific educational background and previous roles are not available.
Erfolgsbilanz: Under Thomas J. Parilla's leadership, Fortitude Group Inc. has focused on developing and marketing medical devices and advanced technology solutions. Key milestones include the company's name change in 2013 and its subsequent efforts to establish a presence in the healthcare sector. Parilla's strategic decisions have centered on expanding the company's product portfolio and forming partnerships to enhance its market reach. Specific financial achievements and performance metrics under his tenure are not available.
FRTD OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Fortitude Group Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in these companies.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure
- Low trading volume and liquidity
- Potential for price manipulation
- Lack of regulatory oversight
- Higher risk of fraud or bankruptcy
- Verify the availability and accuracy of financial reports.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Review the company's legal and regulatory compliance.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor.
- Consider the potential for dilution through future stock offerings.
- Company's focus on medical solutions
- Efforts to improve patient outcomes
- Existence of direct holdings, subsidiaries, and joint ventures
Haeufige Fragen zu FRTD
What are the key factors to evaluate for FRTD?
Fortitude Group, Inc. (FRTD) currently holds an AI score of 48/100, indicating low score. Key strength: Focus on medical device and technology solutions. Primary risk to monitor: Potential: Regulatory hurdles and compliance costs.. This is not financial advice.
How frequently does FRTD data refresh on this page?
FRTD prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven FRTD's recent stock price performance?
Recent price movement in Fortitude Group, Inc. (FRTD) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on medical device and technology solutions. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider FRTD overvalued or undervalued right now?
Determining whether Fortitude Group, Inc. (FRTD) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying FRTD?
Before investing in Fortitude Group, Inc. (FRTD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding FRTD to a portfolio?
Potential reasons to consider Fortitude Group, Inc. (FRTD) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Focus on medical device and technology solutions. Additionally: Potential for improving patient outcomes. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of FRTD?
Yes, most major brokerages offer fractional shares of Fortitude Group, Inc. (FRTD) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track FRTD's earnings and financial reports?
Fortitude Group, Inc. (FRTD) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for FRTD earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited financial data available for Fortitude Group Inc. due to its OTC market listing.
- AI analysis pending for FRTD.